SCHEMBL6854296

SCHEMBL6854296

Cc1nc(OP(=O)(O)O)c(CO)c(C=O)c1O

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX2 Q9UBL9 3/20 0.43
ESR1 P03372 1/20 0.43
PTGS1 P23219 1/20 0.43
ACP1 P24666 1/20 0.43
PDE4A P27815 1/20 0.43
P2RX1 P51575 1/20 0.43
P2RX7 Q99572 2/20 0.42
YWHAG P61981 1/20 0.42
YWHAZ P63104 1/20 0.42
P2RY1 P47900 4/20 0.41
KDM4E B2RXH2 3/20 0.41
MAPT P10636 3/20 0.41
TDP1 Q9NUW8 3/20 0.41
P2RX3 P56373 2/20 0.41
MEN1 O00255 2/20 0.41
HPGD P15428 2/20 0.41
KMT2A Q03164 2/20 0.41
ALDH1A1 P00352 2/20 0.41
HSD17B10 Q99714 1/20 0.41
CASP1 P29466 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10787968 0.78 KDM4E (0.43) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL2692703 0.76 KDM4E (0.50) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL29616270 0.75 KDM4E (0.49) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL4424974 0.72 KDM4E (0.46) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL6938798 0.70 P2RX7 (0.55) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL28432395 0.69 KDM4E (0.43) P2RX2P2RX7YWHAGYWHAZP2RY1
SCHEMBL26180887 0.68 P2RX7 (0.52) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL30621209 0.68 P2RX7 (0.52) P2RX2ESR1PTGS1ACP1PDE4A
SCHEMBL14237027 0.66 ERN1 (0.55) P2RX2ESR1PTGS1ACP1PDE4A
Pyridoxal SCHEMBL584646 0.65 KDM4E (0.78) P2RX2ESR1PTGS1ACP1PDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1000541-B1 Defined serumfree medical solution for ophthalmology SKELNIK DEBRA L (US) 2004-01-14 EP claimed
US-20230372241-A1 SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS FP NUTRACEUTICALS, LLC (US) 2023-11-23 US disclosed
US-20200060964-A1 SACCHARIDE-BASED ORAL MUCOADHESIVE DELIVERY SYSTEM FOR NUTRITIONAL AND NUTRACEUTICAL COMPOSITIONS Food Techonology and Design LLC, DBA FoodPharma (US) 2020-02-27 US disclosed